Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ad-TD-nsIL12 in Primary High-grade Glioma
NCT07126990Phase 2Enrolling by invitation
- Start
- Feb 2025
- Primary completion
- Aug 2028
- Modality
- Oncolytic Viruses
- Countries
- 1
01
Overview
A Phase 2 trial of Ad-TD-nsIL12 in glioma. Started Feb 2025; status: enrolling by invitation.
02
Drugs
Ad-TD-nsIL12
03
Conditions
glioma
Beyond the preview
Go deeper on NCT07126990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07126990.